22 hrs ago
Last week's biggest gainers and losers among Bay State biotechs
Last week was a tough one for publicly traded biotechs, with the Nasdaq Biotechnology Index losing 2.9 percent as new Federal Reserve Chairwoman Janet Yellen singled out biotech stocks as overvalued in comments to U.S. senators.
Friday's ETF Movers: XBI, GDXJ
In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.2% on the day.
ImmunoGen, Inc. Announces Conference Call to Discuss its Fourth...
ImmunoGen, Inc . , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 1, 2014, to discuss ImmunoGen's financial results for the three-month period and fiscal year ended June 30, 2014 and its ... (more)
The Washington Post
U.S. Stock-Index Futures Little Changed Before Data as IMS Gains
U.S. stock-index futures were little changed, after equities slipped for a second day yesterday, as violence in the Middle East increased, and investors awaited data on durable-goods orders in the world's largest economy.